Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.65 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5491392 | 0.98 | TGM2 (0.68) | TGM2TAAR1TRPV1LMNATSHR | |
| SCHEMBL6209769 | 0.95 | TAAR1 (0.69) | TGM2TAAR1LMNATSHRL3MBTL1 | |
| SCHEMBL10808724 | 0.88 | TGM2 (0.60) | TGM2TAAR1TRPV1LMNATSHR | |
| SCHEMBL297599 | 0.88 | ALDH1A1 (0.67) | TGM2TAAR1LMNAHPGDALDH1A1 | |
| SCHEMBL10362383 | 0.85 | TGM2 (0.60) | TGM2TAAR1TRPV1LMNAL3MBTL1 | |
| SCHEMBL8980089 | 0.83 | TRPV1 (0.64) | TAAR1TRPV1LMNATSHRL3MBTL1 | |
| SCHEMBL30764053 | 0.82 | TAAR1 (0.91) | TAAR1TRPV1LMNATSHRL3MBTL1 | |
| Acrylamide SCHEMBL28090758 | 0.82 | ALDH1A1 (0.59) | TGM2TAAR1LMNAHPGDALDH1A1 | |
| Bromide SCHEMBL11227747 | 0.82 | TRPV1 (0.62) | TAAR1TRPV1LMNATSHRL3MBTL1 | |
| SCHEMBL30780863 | 0.82 | POLB (0.58) | TGM2TAAR1TRPV1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1482983-A4 | NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS | YISSUM RES DEV CO (IL) | 2006-07-12 | — | — | EP | claimed |
| EP-1482983-A2 | NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-12-08 | — | — | EP | claimed |
| WO-2003065971-A9 | NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS | YISSUM RES DEV CO (IL) | 2003-11-20 | — | — | WO | claimed |
| WO-2003065971-A2 | NON-MYELOABLATIVE TOLEROGENIC TREATMENT WITH TYRPHOSTINS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2003-08-14 | — | — | WO | claimed |
| US-6379599-B1 | Process for the preparation of molecularly imprinted polymers useful for separation of enzymes | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-04-30 | — | — | US | claimed |
| WO-2025104145-A1 | AN ETCH RESIST INKJET INK | AGFA-GEVAERT NV (BE) | 2025-05-22 | — | — | WO | disclosed |
| EP-4556535-A1 | AN ETCH RESIST INKJET INK | AGFA-GEVAERT NV (BE) | 2025-05-21 | — | — | EP | disclosed |
| EP-3786239-B1 | RADIATION CURABLE COMPOSITION FOR PLATING APPLICATIONS | AGFA GEVAERT NV (BE) | 2023-11-15 | — | — | EP | disclosed |
| US-11492432-B2 | Resin for nanoimprinting, laminate containing resin for nanoimprinting, printed board containing resin for nanoimprinting, and method for producing nanoimprint substrate | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2022-11-08 | — | — | US | disclosed |
| EP-3849538-A1 | COMBINATION THERAPIES | Mirati Therapeutics, Inc. (US) | 2021-07-21 | — | — | EP | disclosed |
| US-20200223125-A1 | RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE | JAPAN SCIENCE & TECH AGENCY (JP) | 2020-07-16 | — | — | US | disclosed |
| WO-2020055756-A1 | COMBINATION THERAPIES | Mirati Therapeutics, Inc. (US) | 2020-03-19 | — | — | WO | disclosed |
| US-20150298387-A1 | RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-0915094-B1 | MORPHINANE DERIVATIVES AND MEDICINAL USE THEREOF | TORAY INDUSTRIES (JP) | 2007-11-07 | — | — | EP | disclosed |
| CN-1150196-C | Morphinane derivatives and medicinal use thereof | ������������ʽ���� | 2004-05-19 | — | — | CN | disclosed |
| US-6379599-B1 | Process for the preparation of molecularly imprinted polymers useful for separation of enzymes | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-04-30 | — | — | US | disclosed |
| US-6187782-B1 | OPIOID EPSILON RECEPTOR AGONISTS AND ANTAGONISTS; SIDE EFFECT REDUCTION; ANALGESICS | TORAY INDUSTRIES, INC. (JP) | 2001-02-13 | — | — | US | disclosed |
| CN-1220667-A | Morphinane derivatives and medicinal use thereof | TORAY INDUSTRIES (JP) | 1999-06-23 | — | — | CN | disclosed |
| EP-0915094-A1 | MORPHINANE DERIVATIVES AND MEDICINAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1999-05-12 | — | — | EP | disclosed |